Wolverine Blend (BPC-157, TB-500) Dosage Guide, Benefits & Side Effects
Wolverine Blend (BPC-157, TB-500) Dosage Guide, Benefits & Side Effects This dual-peptide blend pairs local growth factor signaling with systemic actin-driven repair for tendon, gut, and multi-site recovery. Chemical Makeup 2 Amino Acids Wolverine Blend (BPC-1
Wolverine Blend (BPC-157, TB-500) Dosage Guide, Benefits & Side Effects
This dual-peptide blend pairs local growth factor signaling with systemic actin-driven repair for tendon, gut, and multi-site recovery.
Chemical Makeup
2
Amino Acids
Wolverine Blend (BPC-157, TB-500)
Asn
Position 1
Ala
Position 2
As seen on
Wolverine Blend (BPC-157, TB-500) Dosage Guide for Recovery & RepairWolverine Blend (BPC-157, TB-500) Dosage Calculator
This combines BPC-157 and TB-500, two well-known healing peptides, to speed up tissue recovery from injuries.
Vial size
10 mg
Bacteriostatic water
2 mL
Dosing
250–500 mcg
Frequency
Daily
Cycle
4–8 weeks
Benefit
Recovery & Repair
What is Wolverine Blend (BPC-157, TB-500)?
The Wolverine Stack is a popular combination of two well-studied healing peptides, BPC-157 and TB-500, used together because they support tissue repair in different but complementary ways. BPC-157 helps grow new blood vessels and boosts healing signals at the site of injury, while TB-500 helps cells migrate to the area and calms inflammation throughout the body. It's widely used in research and recovery circles for healing tendon, ligament, and muscle injuries.
Healing
Research targets include tissue repair, wound healing, and recovery from injury.
Longevity
Research targets include cellular aging, senescence, and long-term healthspan.
Performance
Research targets include muscle recovery, endurance, and physical performance pathways.
wol
Is Wolverine Blend (BPC-157, TB-500) FDA approved?
Wolverine Blend (BPC-157, TB-500) is not an FDA-approved drug. It is intended for research purposes only and is not approved for human consumption, diagnostic, or therapeutic use.
Research Use Only
Wolverine Blend (BPC-157, TB-500) has not been evaluated by the FDA for safety or efficacy in humans.
No Clinical Oversight
Not manufactured under FDA-regulated quality or clinical standards.
Unregulated Sourcing
Purity, dosing, and sourcing are not verified through FDA testing or oversight.
Our top-rated vendor
View all vendors
Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.
Based on current scores, this vendor ranks highest across those criteria.
Protide Health
#1 Rated Research Peptide Supplier
How Does Wolverine Blend (BPC-157, TB-500) Work?
BPC-157 switches on blood-vessel-growth and healing signals at the site of injury, while TB-500 grabs onto a cell's internal scaffolding protein (actin) to help cells like blood vessel and skin cells migrate to where they're needed. Together, they also help shift immune cells at the injury site toward a calmer, healing-focused mode.
Grows new blood vessels
BPC-157 switches on blood-vessel-growth and healing signals at the injury.
Speeds up cell movement
TB-500 helps cells migrate quickly to where they're needed.
Shifts immune response
Together they help shift immune cells toward a calmer, healing-focused mode.
Wolverine Blend (BPC-157, TB-500) Targeted areas
How to reconstitute Wolverine Blend (BPC-157, TB-500)
The materials you'll need and step-by-step instructions for safely mixing Wolverine Blend (BPC-157, TB-500) with bacteriostatic water.
Materials needed
Your Wolverine Blend (BPC-157, TB-500) vial (lyophilized)
Alcohol swabs
Bacteriostatic sterile water
3 mL syringes (Luer Lock tip)
25G or 27G needles (Luer Lock). Other gauges may also be acceptable.
Sharps container (optional)
Remove the caps
Sanitize the rubber stoppers
Attach the needle
Draw the bac water
Pull back on the plunger to draw your desired volume of bacteriostatic water. If you overfill, just push the excess back in until you reach the right marker on the syringe.
Insert the needle into the Wolverine Blend (BPC-157, TB-500) vial
With the bac water in your syringe, insert the needle into the Wolverine Blend (BPC-157, TB-500) vial at a slight angle to avoid pressure buildup.
Release the water gently
Let the water run gently down the side of the vial. Don't inject it forcefully.
Swirl to dissolve
Avoid shaking. Gently swirl, flip, and roll the vial to dissolve the powder.
Check for full dissolution
Cap, dispose, and store
How to Store Wolverine Blend (BPC-157, TB-500)
The dry powder can sit at room temperature briefly, or in the fridge for longer storage. Once mixed with bacteriostatic water, refrigerate and use within about two weeks — that limit is set by the shorter-lived of the two peptides — and don't freeze it once mixed.
Lyophilized Storage
Room temperature short-term, or 2–8°C for long-term storage.
Reconstituted Storage
With bacteriostatic water, refrigerate at 2–8°C, use within 14 days (governed by TB-500 stability).
Handling Notes
Do not freeze reconstituted vials.
What Are the Benefits of Wolverine Blend (BPC-157, TB-500)?
What research says it may help with, and how it works in the body.
tissue repair
BPC-157 helps muscle tissue regenerate more effectively, while TB-500 helps cells move to injury sites, a step that is essential for repair.
In a study by Lee and Padgett, 87.5% of patients with knee pain improved after using the combination of BPC-157 and TB4.
Both peptides show signs of speeding up tissue repair; in animal studies, BPC-157 specifically improved healing of the Achilles tendon.
wound healing
In mid-stage clinical trials, TB-500 helped ulcer patients heal roughly a month faster.
antiinflammatory
Both peptides help calm inflammation, though they do so through different processes in the body.
What Are the Side Effects of Wolverine Blend (BPC-157, TB-500)?
Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.
Who Should Avoid It
ANY history of cancer or suspicious growths
Active malignancy or concurrent chemotherapy
Pregnancy or breastfeeding
Stop Right Away If You Notice
Any unusual lumps, growths, or rapid tissue changes
Severe injection site reactions or infections
Signs of allergic reaction (rash, swelling, difficulty breathing)
Unexpected bleeding or bruising
Persistent headaches or vision changes
Any symptoms suggesting abnormal growth
Milder Signs to Watch For
Wolverine Blend (BPC-157, TB-500) contains these peptides
The individual peptides blended together to make Wolverine Blend (BPC-157, TB-500).
bpc
BPC-157
Preclinical
tb5
TB-500
How Long Should a Wolverine Blend (BPC-157, TB-500) Cycle Last?
This breaks down how long a typical Wolverine Blend (BPC-157, TB-500) cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.
That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.
Related peptides
Growth
mgf
MGF
Metabolic
mot
MOTS-c
Phase 1
nad
NAD+
Experimental
ova
Ovagen
Cheat Sheets Featuring Wolverine Blend (BPC-157, TB-500)
See how Wolverine Blend (BPC-157, TB-500) fits into a broader research stack with these free downloadable cheat sheets. Each one includes reference dose ranges, dosing frequency, and half-life for every peptide it covers. For research purposes only.
18 peptides
42 peptides
78 peptides
Browse user-created protocols
Real protocols from the community that include Wolverine Blend (BPC-157, TB-500)
Body Recomposition Phase 3
Joe
Weight
GLP-2
tes
ghk
Longevity Stack
John
tesa
Wolverine Blend (BPC-157, TB-500) Research References
It is a preclinical compound
Wolverine Blend (BPC-157, TB-500) is a preclinical compound
16 patients, intra-articular injection: Overall 87.5% (14/16) experienced knee pain relief. BPC-157 alone: 91.6% improvement (11/12). BPC-157 + TB4 combination: 75% improvement (3/4).
2021
Two Phase 2 clinical trials showed thymosin β4 accelerated wound healing by approximately one month in responsive ulcer patients.
2012
Comprehensive review establishing thymosin β4 as regenerative, promoting cell migration, reducing inflammation/apoptosis, and decreasing scar formation.
Rats, 10 μg/kg i.p. daily, 14 days: BPC-157 demonstrated superior healing of transected Achilles tendons with improved biomechanical properties.
2003
Rats, full thickness wounds: Topical or intraperitoneal Tβ4 increased re-epithelialization by 42% at 4 days and up to 61% at 7 days.
1999
36 articles reviewed. Preclinical models showed improvements in muscle tears, tendon ruptures, ligament tears, and fracture healing. Mechanism involves enhanced GH receptor expression and angiogenesis.
2025
Frequently Asked Questions About Wolverine Blend (BPC-157, TB-500)
Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.
What is the "Wolverine Stack" and why is it called that?
The Wolverine Stack is the informal name for combining two peptides — BPC-157 (a synthetic pentadecapeptide based on a protective compound found in gastric juice) and TB-500 (a synthetic version of a fragment of thymosin beta-4) — with the goal of supporting tissue repair and recovery. The nickname is a pop-culture reference to the Marvel character known for rapid healing; it is not a clinical or regulatory term, and no product is officially named or approved as such. The rationale behind stacking the two is that BPC-157 is thought to act more locally on injured tissue while TB-500 is thought to act more systemically, so combining them is meant to cover both angles.
What dosages are commonly used in the Wolverine Stack, and how is it cycled?
Protocols circulating among users and vendor sites vary, but commonly cited ranges are BPC-157 at roughly 250–500 mcg per day (some go up to ~750 mcg–1 mg/day) and TB-500 at about 2–5 mg, one to two times per week, often with a higher "loading" dose in the first weeks followed by a lower maintenance dose. Typical cycle lengths range from about 4 to 8 weeks, sometimes extending to 12 weeks for chronic issues, followed by a break. These figures come from research-community and vendor sources rather than clinical trials in humans, so there is no officially validated or standardized dose, and actual products vary in concentration and purity.
How is BPC-157/TB-500 typically administered?
Both peptides are most commonly used as injectable solutions after being reconstituted from a lyophilized (freeze-dried) powder with bacteriostatic or sterile water, then given by subcutaneous or intramuscular injection. BPC-157 is often injected subcutaneously near the site of an injury, while TB-500 is generally injected systemically since its effects are described as more whole-body. Oral BPC-157 capsules also exist but are widely considered less reliably absorbed than injectable forms. None of these delivery methods have FDA-approved dosing or administration guidelines.
How long do BPC-157 and TB-500 last in the body, and how should they be stored?
BPC-157 has a short reported half-life in animal studies (well under an hour, with clearance from the bloodstream estimated around 4–6 hours), which is one reason it's often dosed daily or multiple times per day. TB-500 is generally described as having a longer duration of action, which is why it's typically dosed only once or twice a week rather than daily. For storage, lyophilized (powder) peptide is usually kept frozen or refrigerated and protected from light until use; once reconstituted, both peptides are typically stored refrigerated (about 2–8°C), away from light and heat, and used within roughly 4–6 weeks, avoiding repeated freeze-thaw cycles.
What side effects or risks are associated with this stack?
In published animal studies, BPC-157 has shown a favorable safety profile with few adverse effects reported, but robust human clinical safety data for either peptide is limited. Commonly reported (largely anecdotal) issues include injection-site reactions (redness, itching, minor bruising or lumps), headache, dizziness, nausea, or fatigue, particularly at higher doses. Because these are unregulated, research-grade products, there is also risk from product impurity, incorrect dosing, and unknown long-term effects, since long-duration human safety and efficacy trials have not been completed.
Is BPC-157/TB-500 legal, and is it FDA-approved?
Neither BPC-157 nor TB-500 is approved by the FDA for any medical use in humans, and neither has an official USP/NF monograph. They are not scheduled controlled substances, but they occupy a regulatory gray zone: both were previously flagged by the FDA on its list of bulk substances with safety concerns for compounding, and as of 2026 their compounding status remains under active review by the FDA's Pharmacy Compounding Advisory Committee. Some vendors sell them labeled "for research use only, not for human consumption," which reflects their unapproved status rather than an endorsement of off-label human use. Regulations can vary by country and may change, so anyone considering these compounds should check current local rules.
What is this stack claimed to be used for?
Proponents and vendor marketing describe the Wolverine Stack as being explored for supporting recovery from soft-tissue injuries (tendons, ligaments, muscle), post-surgical or post-workout recovery, joint discomfort, and general tissue repair, based on preclinical research into BPC-157's and TB-500's roles in angiogenesis, cell migration, and wound healing. These are not established, FDA-recognized medical uses, and most supporting evidence comes from animal or in-vitro studies rather than controlled human trials, so specific efficacy claims for humans are not well substantiated.
Can BPC-157 and TB-500 be combined with other peptides or compounds?
Some research and biohacking communities discuss adding other peptides (such as GHK-Cu or KPV) to the base BPC-157/TB-500 stack for additional skin, anti-inflammatory, or cosmetic effects, and some also mention pairing it with growth-hormone-related peptides for recovery purposes. There is no clinical evidence establishing safe or effective combined dosing for these multi-peptide stacks, and combining unregulated compounds increases the number of unknowns around interactions and side effects. Anyone considering combining substances should be aware this further departs from any tested protocol.